A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

IsraelRecruitingPHASE3

Conditions

Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • USA Mitchell Cancer Institute ( Site 0014), Mobile, Alabama, United States

    Study coordinator · 251-665-8000
  • Banner MD Anderson Cancer Center ( Site 0059), Gilbert, Arizona, United States

    Study coordinator · 480-256-5490
  • Banner MD Anderson Cancer Center - University Medical Center Phoenix ( Site 0051), Phoenix, Arizona, United States

    Study coordinator · 480-256-5490
  • Arizona Oncology Associates - NAHOA ( Site 8007), Prescott, Arizona, United States

  • Alta Bates Summit Medical Center ( Site 0004), Berkeley, California, United States

    Study coordinator · 510-204-3428
  • Moores Cancer Center ( Site 0003), La Jolla, California, United States

    Study coordinator · 858-534-5201
  • Care Access - South Pasadena ( Site 0070), Pasadena, California, United States

    Study coordinator · 626-556-9930
  • Saint Joseph Hospital ( Site 0026), Denver, Colorado, United States

    Study coordinator · 303-403-6381
  • Lutheran Medical Center ( Site 0027), Golden, Colorado, United States

    Study coordinator · 303-403-6381
  • Intermountain Health St. Mary's Regional Hospital ( Site 0025), Grand Junction, Colorado, United States

    Study coordinator · 970-298-7638
  • Eastern CT Hematology & Oncology Associates ( Site 0033), Norwich, Connecticut, United States

    Study coordinator · 860-886-8362
  • Clermont Oncology Center ( Site 0046), Clermont, Florida, United States

    Study coordinator · 386-538-3169
  • Florida Cancer Specialists - South ( Site 7001), Fort Myers, Florida, United States

    Study coordinator · 239-274-9930
  • Florida Cancer Specialists - East ( Site 7002), West Palm Beach, Florida, United States

    Study coordinator · 727-216-1143
  • Parkview Research Center at Parkview Regional Medical Center ( Site 0002), Fort Wayne, Indiana, United States

    Study coordinator · 260-266-7100
  • University of Iowa Health Care. ( Site 0017), Waukee, Iowa, United States

    Study coordinator · 319-356-1616
  • University of Iowa Health Care. ( Site 0057), Waukee, Iowa, United States

    Study coordinator · 319-356-1616
  • Saint Elizabeth Healthcare ( Site 0041), Edgewood, Kentucky, United States

    Study coordinator · 859-301-2000
  • Corewell Health-Lemmon Holton Cancer Pavilion ( Site 0011), Grand Rapids, Michigan, United States

    Study coordinator · 616-267-7566
  • Regions Hospital ( Site 0042), Saint Louis Park, Minnesota, United States

    Study coordinator · 952-993-3252
  • MidAmerica Cancer Care, LLC ( Site 0043), Kansas City, Missouri, United States

    Study coordinator · 816-974-5050
  • Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana ( Site 0052), Billings, Montana, United States

    Study coordinator · 406-238-6685
  • Summit Medical Group Cancer Center ( Site 0007), Florham Park, New Jersey, United States

  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0016), Hackensack, New Jersey, United States

    Study coordinator · 551-996-3277
  • New York Oncology Hematology, P.C. ( Site 0069), Albany, New York, United States

    Study coordinator · 518-262-6696
  • Roswell Park Cancer Institute ( Site 0023), Buffalo, New York, United States

    Study coordinator · 716-845-2300
  • RPCI Oncology, PC- Northtowns ( Site 0061), Williamsville, New York, United States

    Study coordinator · 716-634-3340
  • Carolina Oncology Specialists, PA ( Site 0054), Charlotte, North Carolina, United States

    Study coordinator · 704-342-1900
  • Southeastern Medical Oncology Center ( Site 0049), Goldsboro, North Carolina, United States

    Study coordinator · 919-587-9088
  • Consultants in Medical Oncology and Hematology (CMOH) ( Site 8002), Broomall, Pennsylvania, United States

    Study coordinator · 610-585-6287
  • Cancer Care Associates Of York ( Site 0005), York, Pennsylvania, United States

    Study coordinator · 717-741-9229
  • Tennessee Oncology-Chattanooga ( Site 0045), Chattanooga, Tennessee, United States

    Study coordinator · 615-986-4350
  • Tennessee Oncology, PLLC - Elliston Place Plaza Medical Oncology & Hematology ( Site 0031), Nashville, Tennessee, United States

    Study coordinator · 615-986-4350
  • Texas Oncology - Central/South Texas ( Site 8008), Austin, Texas, United States

    Study coordinator · 512-421-4100
  • The Center for Cancer and Blood Disorders ( Site 0032), Fort Worth, Texas, United States

    Study coordinator · 817-759-7013
  • Texas Oncology - San Antonio ( Site 8006), San Antonio, Texas, United States

    Study coordinator · 210-419-2608
  • Texas Oncology - Northeast Texas ( Site 8012), Tyler, Texas, United States

    Study coordinator · 903-579-9800
  • University of Virginia Cancer Center ( Site 0040), Charlottesville, Virginia, United States

    Study coordinator · 434-243-2649
  • Inova Schar Cancer Institute ( Site 0015), Fairfax, Virginia, United States

    Study coordinator · 571-472-4724
  • Virginia Commonwealth University (VCU) Medical Center ( Site 0030), Richmond, Virginia, United States

    Study coordinator · 804-628-2072
  • Medical Oncology Associates, PS (dba Summit Cancer Centers) ( Site 0010), Spokane, Washington, United States

    Study coordinator · 509-462-2273
  • SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical ( Site 0048), Madison, Wisconsin, United States

    Study coordinator · 608-410-2700
  • University Hospital and UW Health Clinics ( Site 0006), Madison, Wisconsin, United States

    Study coordinator · 608-263-6400
  • Royal North Shore Hospital ( Site 2806), St Leonards, New South Wales, Australia

  • AZ Sint-Maarten, Campus Leopoldstraat 2 ( Site 0205), Mechelen, Antwerpen, Belgium

    Study coordinator · +3215892080
  • UZ Leuven-Hematology ( Site 0200), Leuven, Vlaams-Brabant, Belgium

    Study coordinator · +3216332211
  • Hospital 9 De Julho ( Site 2206), São Paulo, São Paulo, Brazil

    Study coordinator · 55 11 3147 9432
  • Instituto Nacional de Câncer - INCA ( Site 2201), Rio de Janeiro, Brazil

    Study coordinator · +2132076585
  • Hospital Paulistano-Americas Oncologia ( Site 2202), São Paulo, Brazil

    Study coordinator · 55 11 11 3141-1083
  • BC Cancer Kelowna ( Site 0112), Kelowna, British Columbia, Canada

    Study coordinator · 250-717-4294
  • BC Cancer Victoria ( Site 0109), Victoria, British Columbia, Canada

    Study coordinator · 250-519-5500
  • William Osler Health System ( Site 0103), Brampton, Ontario, Canada

    Study coordinator · 905-494-2120
  • The Ottawa Hospital - General Campus ( Site 0102), Ottawa, Ontario, Canada

    Study coordinator · 613-737-8899 x79509
  • McGill University Health Centre ( Site 0106), Montreal, Quebec, Canada

    Study coordinator · 514-934-1934
  • Centre intégré de santé et de services sociaux du Bas Saint-Laurent- Hôpital régional de Rimouski ( Site 0100), Rimouski, Quebec, Canada

  • FALP-UIDO ( Site 2300), Santiago, Region M. de Santiago, Chile

    Study coordinator · 56224205098
  • Clínica Alemana de Santiago-Unidad de Investigaciones ( Site 2306), Santiago, Region M. de Santiago, Chile

    Study coordinator · 56222101111 (6218)
  • Bradfordhill-Clinical Area ( Site 2310), Santiago, Region M. de Santiago, Chile

    Study coordinator · 56229490970
  • Anhui Provincial Cancer Hospital Clinical Trial Ethics Committee ( Site 2001), Hefei, Anhui, China

    Study coordinator · 0551-65329163
  • Peking University First Hospital ( Site 2022), Beijing, Beijing Municipality, China

    Study coordinator · 010-83575680
  • Peking University Third Hospital-Hematology ( Site 2011), Beijing, Beijing Municipality, China

    Study coordinator · 010-82264404
  • Chongqing University Cancer Hospital ( Site 2041), Chongqing, Chongqing Municipality, China

    Study coordinator · 02365079270
  • Sun Yat-sen University Cancer Center ( Site 2028), Guangzhou, Guangdong, China

    Study coordinator · 020-87343886
  • Southern Medical University Nanfang Hospital-Department of Hematopathology ( Site 2006), Guangzhou, Guangdong, China

    Study coordinator · +86 02062786845
  • Liuzhou People's Hospital ( Site 2029), Liuzhou, Guangxi, China

    Study coordinator · 0772-3612345
  • Guangxi Medical University Affiliated Tumor Hospital ( Site 2004), Nanning, Guangxi, China

    Study coordinator · 0771-5313603
  • The Affiliated Hospital of Guizhou Medical University ( Site 2024), Guiyang, Guizhou, China

    Study coordinator · 0851-86740793
  • Hainan General Hospital ( Site 2018), Haikou, Hainan, China

    Study coordinator · (0898)68622479
  • Henan Cancer Hospital-hematology department ( Site 2025), Zhengzhou, Henan, China

    Study coordinator · 0371-65587305
  • Tongji Hospital Affiliated to Tongji Medical College of HUST ( Site 2016), Wuhan, Hubei, China

    Study coordinator · 02783662640
  • Ethics Committee of Union Hospital Tongji Medical College Huazhong University of Science and Technol ( Site 2015), Wuhan, Hubei, China

    Study coordinator · 02784397521
  • Hunan Cancer Hospital ( Site 2020), Changsha, Hunan, China

    Study coordinator · 0731-89762281
  • The Second Xiangya Hospital of Central South University ( Site 2010), Changsha, Hunan, China

    Study coordinator · +86 073185292097
  • Jiangsu Province Hospital ( Site 2000), Nanjing, Jiangsu, China

    Study coordinator · 025-68307358
  • The First Affliated Hospital of Suzhou University ( Site 2027), Suzhou, Jiangsu, China

    Study coordinator · 0512-67972858
  • The Affiliated Hospital of Xuzhou Medical College ( Site 2013), Xuzhou, Jiangsu, China

    Study coordinator · 051685802369
  • The First Affiliated Hospital of Nanchang University ( Site 2023), Nanchang, Jiangxi, China

    Study coordinator · 0791-88695051
  • Jiangxi Provincial Cancer Hospital ( Site 2009), Nanchang, Jiangxi, China

    Study coordinator · 079188329441
  • The First Hospital of Jilin University-Hematology ( Site 2030), Changchun, Jilin, China

    Study coordinator · 0431-81879901
  • Shaanxi provincial people's hospital ( Site 2012), Xi'an, Shaanxi, China

    Study coordinator · 029-85251331
  • Shandong Cancer Hospital ( Site 2003), Jinan, Shandong, China

    Study coordinator · 0531-87984777
  • Shanxi Cancer Hospital ( Site 2033), Taiyuan, Shanxi, China

    Study coordinator · 0351-4651037
  • West China Hospital, Sichuan University-Head and Neck Oncology ( Site 2026), Chengdu, Sichuan, China

    Study coordinator · 02885423278
  • Tianjin Medical University Cancer Institute & Hospital-lymphoma ( Site 2019), Tianjin, Tianjin Municipality, China

    Study coordinator · 022-23340123-2071
  • Institute of hematology&blood disease hospital-Lymphoma ( Site 2005), Tianjin, Tianjin Municipality, China

    Study coordinator · 022-23608110
  • Xinjiang Medical University Cancer Hospital - Urumqi ( Site 2014), Ürümqi, Xinjiang, China

    Study coordinator · 0991-7968088
  • The first Affiliated Hospital, Zhejiang University School of Medicine-Hematology ( Site 2002), Hangzhou, Zhejiang, China

    Study coordinator · 057187236114
  • Zhejiang Cancer Hospital ( Site 2017), Hangzhou, Zhejiang, China

    Study coordinator · 0571-88122198
  • Sociedad De Oncología y Hematología Del Cesar SAS-Oncology ( Site 2405), Valledupar, Cesar Department, Colombia

    Study coordinator · +57 315 8505190
  • IMAT S.A.S ( Site 2401), Montería, Departamento de Córdoba, Colombia

    Study coordinator · +57 3135342052
  • Fundacion Valle del Lili- CIC-Oncology CIC ( Site 2402), Cali, Valle del Cauca Department, Colombia

    Study coordinator · +576023319090 - 4022
  • Fakultni nemocnice Hradec Kralove-IV. interni hematologicka klinika ( Site 0301), Hradec Králové, Czechia

    Study coordinator · +420 777846836
  • Fakultni nemocnice Olomouc ( Site 0303), Olomouc, Czechia

    Study coordinator · +420588443940
  • Vseobecna fakultni nemocnice v Praze-I. Interní klinika - klinika hematologie ( Site 0302), Prague, Czechia

    Study coordinator · +420224962527
  • Aalborg Universitetshospital, Syd ( Site 0403), Aalborg, North Denmark, Denmark

    Study coordinator · +45 97660000
  • Roskilde Sygehus-Department of Hematology ( Site 0402), Roskilde, Region Sjælland, Denmark

    Study coordinator · +45 46323200
  • Odense Universitetshospital-Department of Hematology ( Site 0401), Odense C, Region Syddanmark, Denmark

    Study coordinator · +4566613333
  • Universitaetsklinikum Ulm. ( Site 0601), Ulm, Baden-Wurttemberg, Germany

    Study coordinator · +497315000
  • VK&K Studien GbR ( Site 0607), Landshut, Bavaria, Germany

    Study coordinator · +4987197403429
  • Kliniken Maria Hilf ( Site 0603), Mönchengladbach, North Rhine-Westphalia, Germany

    Study coordinator · +4921618922201
  • InVO Institut für Versorgungsforschung in der Onkologie ( Site 0606), Koblenz, Rhineland-Palatinate, Germany

    Study coordinator · +4926192156930
  • Universitätsklinikum Halle ( Site 0604), Halle, Saxony-Anhalt, Germany

    Study coordinator · +493455572054
  • Onkologische Schwerpunktpraxis Kurfuerstendamm ( Site 0600), Berlin, Germany

    Study coordinator · +4930887742570
  • Evangelismos General Hospital of Athens ( Site 0700), Athens, Attica, Greece

    Study coordinator · 0030 2132041721
  • General Hospital of Athens "Laiko" ( Site 0704), Athens, Attica, Greece

    Study coordinator · 0030 2132061643
  • University Hospital of Alexandroupolis ( Site 0701), Alexandroupoli, East Macedonia and Thrace, Greece

    Study coordinator · 0030 2551353739
  • University Hospital of Ioannina ( Site 0702), Ioannina, Greece

    Study coordinator · +302651099647
  • Queen Mary Hospital ( Site 3300), Hong Kong, Hong Kong

    Study coordinator · +852 2255 3838
  • Rambam Health Care Campus-Hematology and Bone Marrow Transplantation ( Site 1503), Haifa, Israel

    Study coordinator · 04-7771514
  • Bnai Zion Medical Center ( Site 1505), Haifa, Israel

    Study coordinator · 972506268114
  • Hadassah Medical Center-Hemato-Oncology ( Site 1500), Jerusalem, Israel

    Study coordinator · 972-56-9101736
  • Galilee Medical Center ( Site 1507), Nahariya, Israel

    Study coordinator · +97249107260
  • Rabin Medical Center ( Site 1504), Petah Tikva, Israel

    Study coordinator · 972-54-2200162
  • Sheba Medical Center-Hemato Oncology ( Site 1501), Ramat Gan, Israel

    Study coordinator · +972-35308401
  • Yitzhak Shamir Medical Center. ( Site 1506), Ẕerifin, Israel

    Study coordinator · 972-8-9542443
  • Nagoya University Hospital ( Site 1907), Nagoya, Aichi-ken, Japan

  • Gunma University Hospital ( Site 1903), Maebashi, Gunma, Japan

  • Hokkaido University Hospital ( Site 1900), Sapporo, Hokkaido, Japan

  • Kobe City Medical Center General Hospital ( Site 1910), Kobe, Hyōgo, Japan

  • Tohoku University Hospital ( Site 1901), Sendai, Miyagi, Japan

  • Kindai University Hospital ( Site 1909), Sakai, Osaka, Japan

  • Shimane University Hospital ( Site 1911), Izumo, Shimane, Japan

  • Cancer Institute Hospital of JFCR ( Site 1906), Koto, Tokyo, Japan

  • Chiba Cancer Center ( Site 1905), Chiba, Japan

  • Kyushu University Hospital ( Site 1914), Fukuoka, Japan

  • Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital ( Site 1913), Hiroshima, Japan

  • Okayama University Hospital ( Site 1912), Okayama, Japan

  • Japanese Red Cross Osaka Hospital ( Site 1908), Osaka, Japan

  • Yamagata University Hospital ( Site 1902), Yamagata, Japan

  • University Malaya Medical Centre ( Site 1604), Lembah Pantai, Kuala Lumpur, Malaysia

    Study coordinator · +60479492351
  • Hospital Pulau Pinang ( Site 1602), George Town, Pulau Pinang, Malaysia

    Study coordinator · +6042225767
  • Queen Elizabeth Hospital ( Site 1603), Kota Kinabalu, Sabah, Malaysia

    Study coordinator · +6088517555
  • Centro de Infusion Superare ( Site 2602), Mexico City, Mexico City, Mexico

    Study coordinator · 5525020124
  • Health Pharma Professional Research S.A. de C.V: ( Site 2608), Mexico City, Mexico City, Mexico

  • Grupo Médico ASSET ( Site 2611), Mexico City, Mexico

    Study coordinator · +525516217417
  • Waikato Hospital-Haematology ( Site 3202), Hamilton, Waikato Region, New Zealand

    Study coordinator · +64 7 839 8899
  • North Shore Hospital-Department of Haematology ( Site 3200), Auckland, New Zealand

    Study coordinator · +64 9 486 8930
  • Aotearoa Clinical Trials ( Site 3201), Auckland, New Zealand

    Study coordinator · (+64)0800272784
  • Akershus Universitetssykehus ( Site 0902), Lørenskog, Akershus, Norway

    Study coordinator · +4767 96 00 00
  • Sykehuset i Vestfold ( Site 0903), Tønsberg, Vestfold, Norway

    Study coordinator · +4733342000
  • Oslo Universitetssykehus Rikshospitalet-Avdeling for blodsykdommer ( Site 0901), Oslo, Norway

    Study coordinator · +4791502770
  • Centro Medico Monte Carmelo-Oncology ( Site 2706), Arequipa, Ariqipa, Peru

    Study coordinator · +51980728089
  • Clínica Anglo Americana ( Site 2701), Lima, Peru

    Study coordinator · +5116168900
  • Pratia MCM Krakow ( Site 1007), Krakow, Lesser Poland Voivodeship, Poland

    Study coordinator · 0048602338290
  • Uniwersytecki Szpital Kliniczny nr 1 w Lublinie-Oddział Hematoonkologii-Transplantacji Szpiku i Chem ( Site 1006), Lublin, Lublin Voivodeship, Poland

    Study coordinator · +48 81 534 54 68
  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Kilinka Onkologii I Hematologii ( Site 1004), Warsaw, Masovian Voivodeship, Poland

    Study coordinator · +48225462223
  • Uniwersyteckie Centrum Kliniczne-Klinika Hematologii i Transplantologii ( Site 1011), Gdansk, Pomeranian Voivodeship, Poland

    Study coordinator · +48 58 584 43 57
  • Wojewódzki Szpital Specjalistyczny im. J. Korczaka w Słupsku-Oddział Hematologii i Transplantacji ( Site 1013), Słupsk, Pomeranian Voivodeship, Poland

  • Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 1000), Gliwice, Silesian Voivodeship, Poland

    Study coordinator · +48322788523
  • Pratia Onkologia Katowice ( Site 1009), Katowice, Silesian Voivodeship, Poland

    Study coordinator · +48501714019
  • Samodzielny Publiczny Zakład Opieki Zdrowotnej MSWiA w Olsztynie-Oddzial Kliniczny Hematologii ( Site 1005), Olsztyn, Warmian-Masurian Voivodeship, Poland

    Study coordinator · 48895398133
  • Instituto Português de Oncologia de Lisboa Francisco Gentil ( Site 3103), Lisbon, Lisbon District, Portugal

    Study coordinator · 00351217229800
  • Champalimaud Foundation ( Site 3102), Lisbon, Lisbon District, Portugal

    Study coordinator · 00351210480200
  • Unidade Local de Saude Gaia/Espinho - Hospital Eduardo Santos Silva ( Site 3107), Vila Nova de Gaia, Porto District, Portugal

    Study coordinator · 00351227865100
  • Unidade Local de Saude Lisboa Ocidental - Hospital de São Francisco Xavier ( Site 3104), Lisbon, Portugal

    Study coordinator · 00351210431703
  • Unidade Local de Saude de Santa Maria - Hospital de Santa Maria ( Site 3106), Lisbon, Portugal

    Study coordinator · +351217805000
  • Instituto Português de Oncologia do Porto Francisco Gentil, EPE ( Site 3100), Porto, Portugal

    Study coordinator · 00351225084000
  • Wits Clinical Research ( Site 1102), Johannesburg, Gauteng, South Africa

    Study coordinator · +27119836501
  • Netcare Pretoria East Hospital-Alberts Cellular Therapy ( Site 1101), Pretoria, Gauteng, South Africa

    Study coordinator · +27 12 993 2555
  • Groote Schuur Hospital-Clinical Haematology ( Site 1100), Cape Town, Western Cape, South Africa

    Study coordinator · +27727689024
  • Haemalife ( Site 1105), Kuilsriver, Western Cape, South Africa

    Study coordinator · +27219006277
  • Constantiaberg Haematology ( Site 1106), Plumstead, Western Cape, South Africa

    Study coordinator · 0217992558
  • Institut Català d'Oncologia - L'Hospitalet-Haematology Department ( Site 1207), L'Hospitalet Del Llobregat, Barcelona, Spain

    Study coordinator · + 34 932607750
  • HOSPITAL CLÍNIC DE BARCELONA ( Site 1202), Barcelona, Catalonia, Spain

    Study coordinator · +34 619085109
  • HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID ( Site 1209), Pozuelo de Alarcón, Madrid, Spain

    Study coordinator · +34 914521900
  • HOSPITAL UNIVERSITARIO PUERTA DE HIERRO MAJADAHONDA ( Site 1208), Majadahonda, Madrid, Comunidad de, Spain

    Study coordinator · +34 911917620
  • hospital universitario de canarias ( Site 1205), San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain

    Study coordinator · +34922678207
  • Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 1206), Barcelona, Spain

    Study coordinator · +34 934893806
  • Hospital Universitario de Salamanca - Complejo Asistencial U-Servicio de Hematologia ( Site 1201), Salamanca, Spain

    Study coordinator · 923291100 Ext. 55014
  • Karolinska Universitetssjukhuset Solna ( Site 1302), Stockholm, Stockholm County, Sweden

    Study coordinator · +46812370000
  • Chang Gung Memorial Hospital at Kaohsiung-Division of Hematology and Oncology ( Site 1702), Kaohsiung City, Taiwan

    Study coordinator · +88677317123
  • National Cheng Kung University Hospital ( Site 1700), Tainan, Taiwan

    Study coordinator · +88662752037
  • National Taiwan University Hospital ( Site 1701), Taipei, Taiwan

    Study coordinator · +886972652039
  • Chang Gung Medical Foundation-Linkou Branch ( Site 1703), Taoyuan, Taiwan

    Study coordinator · +88633281200
  • Faculty of Medicine Siriraj Hospital-Division of Hematology, Department of Medicine ( Site 1801), Bangkok, Bangkok, Thailand

    Study coordinator · +6624197767
  • Chulalongkorn University ( Site 1802), Pathumwan, Bangkok, Thailand

    Study coordinator · +6624197767
  • Naresuan University Hospital ( Site 1804), Muang, Changwat Phitsanulok, Thailand

    Study coordinator · +6655965777
  • Songklanagarind hospital ( Site 1803), Hat Yai, Changwat Songkhla, Thailand

    Study coordinator · 6674451735
  • Maharaj Nakorn Chiang Mai Hospital ( Site 1800), Muang, Chiang Mai, Thailand

    Study coordinator · 6653935488
  • Ankara Universitesi Tip Fakultesi Hastanesi-hematology ( Site 1401), Ankara, Turkey (Türkiye)

    Study coordinator · +90312 310 33 33
  • Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 1407), Ankara, Turkey (Türkiye)

    Study coordinator · +90 312 552 60 00
  • Antalya Egitim ve Arastırma Hastanesi ( Site 1409), Antalya, Turkey (Türkiye)

    Study coordinator · +90 242 2494400-4143
  • Trakya University Medical Faculty Hospital-Hematology ( Site 1403), Edirne, Turkey (Türkiye)

    Study coordinator · +905438561362
  • Mega Medipol ( Site 1412), Istanbul, Turkey (Türkiye)

    Study coordinator · +90 5077078197
  • Sisli Florence Nightingale Hastanesi ( Site 1411), Istanbul, Turkey (Türkiye)

    Study coordinator · +90444 04 36
  • Marmara Universitesi Pendik Egitim Arastirma Hastanesi ( Site 1408), Istanbul, Turkey (Türkiye)

  • Ege Universitesi Hastanesi ( Site 1404), Izmir, Turkey (Türkiye)

    Study coordinator · +905325566128
  • Ondokuz Mays Üniversitesi ( Site 1410), Samsun, Turkey (Türkiye)

    Study coordinator · +903624576041
  • Southmead Hospital ( Site 3010), Bristol, Bristol, City of, United Kingdom

  • Royal Lancaster Infirmary ( Site 3012), Lancaster, Lancashire, United Kingdom

    Study coordinator · 01524 512128
  • St Bartholomew's Hospital-Centre for Experimental Cancer Medicine ( Site 3006), London, London, City of, United Kingdom

    Study coordinator · +442073777000
  • The Churchill Hospital ( Site 3007), Oxford, Oxfordshire, United Kingdom

    Study coordinator · 441865235886
  • GenesisCare - Bristol ( Site 3011), Bristol, South Gloucestershire, United Kingdom

    Study coordinator · +441173421121
  • GenesisCare - Cambridge ( Site 3001), Newmarket, Suffolk, United Kingdom

    Study coordinator · 01223 907622
  • GenesisCare - Windsor ( Site 3002), Windsor, Windsor And Maidenhead, United Kingdom

    Study coordinator · 447989474250
  • Barnet Hospital ( Site 3005), Barnet, United Kingdom

    Study coordinator · 0208 216 4755
  • St James's University Hospital ( Site 3004), Leeds, United Kingdom

    Study coordinator · +441132432799
  • City Hospital, Nottingham University Hospitals NHS Trust ( Site 3003), Nottingham, United Kingdom

Study leads
  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC